Registry for kidney issues in COVID-19 patients
Kidney in Coronavirus Disease 2019 Registry
This study is looking at how COVID-19 affects kidney health in patients who have had kidney injuries to help improve future treatments for these complications.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | University of Cologne Academic / other |
| Locations | 1 site (Cologne) |
| Trial ID | NCT04797091 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and analyze data on patients with COVID-19, specifically focusing on those who experience acute kidney injury (AKI). By utilizing a matched case-control design, the study seeks to understand the clinical course of COVID-19 and its impact on kidney health, as well as the associated mortality and costs. The research will involve retrospective data collection from patients who have virology and pathological evidence of SARS-CoV-2 infection. The findings will help establish future treatment approaches for COVID-19-related kidney complications.
Who should consider this trial
Good fit: Ideal candidates include patients with confirmed SARS-CoV-2 infection who are experiencing acute kidney injury.
Not a fit: Patients with acute respiratory distress syndrome or acute kidney injury without evidence of SARS-CoV-2 infection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of kidney complications in COVID-19 patients.
How similar studies have performed: Other studies have indicated significant health impacts of COVID-19 on kidney function, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Virology evidence of SARS-CoV-2-infection * Pathological evidence of SARS-CoV-2-infection Exclusion Criteria: * Occurrence of ARDS (acute respiratory distress syndrome) without evidence of SARS-CoV-2 infection * Acute kidney injury without evidence of SARS-CoV-2 infection
Where this trial is running
Cologne
- University Hospital of Cologne — Cologne, Germany (Recruiting)
Study contacts
- Principal investigator: Volker Burst, PD MD — University Hospital of Cologne
- Study coordinator: Felix Köhler, MD
- Email: felix.koehler@uk-koeln.de
- Phone: +4922147897222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.